fda glp-1 compounding crackdown news october 2025 is short-sighted on GLP-1s New project announcement: HHS‑OIG is

As a result, the brain releases more of the hunger hormone ghrelin and dials down leptin, one of the hormones that signals fullness and energy sufficiency

120(10S2): p S168, October 2025

Numerous other trials have demonstrated positive cardiovascular outcomes with focus on HFpEF in the SUMMIT trial for tirzepatide and the STEP-HFpEF trial for semaglutide [50,51,52]

Using GLP-1s for depression, however, has been met with skepticism

This individualized approach means that two people at identical weights may have different treatment recommendations based on their age, metabolic profile, and existing medical conditions